Literature DB >> 16411393

Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.

Ilse Mertens1, Dominique Ballaux, Tohru Funahashi, Yuji Matsuzawa, Marc Van der Planken, An Verrijken, Johannes B Ruige, Luc F Van Gaal.   

Abstract

Adipose tissue is an active endocrine organ secreting different adipokines such as plasminogen activator inhibitor-1 (PAI-1) and adiponectin, among many others. In this study, we investigated the association between PAI-1 activity and serum adiponectin levels in a group of 444 overweight and obese women and assessed the interrelationship with visceral adipose tissue (VAT; CT-scan L4-L5), insulin resistance (HOMA-IR), HDL cholesterol (HDL-chol) and inflammation (hs-CRP). PAI-1 was inversely related to adiponectin (r = -0.25, p < 0.001; adjusted for age and BMI). After adjustment for age, VAT, HOMA-IR and hs-CRP, the relationship remained significant (r = -0.15; p = 0.001), but disappeared after additional adjustment for HDL-chol (r = -0.09; p = 0.067). Subjects were divided in two groups according to the median levels of adiponectin or PAI-1 levels. PAI-1 activity (19.1 +/- 11.4 vs. 15.8 +/- 8.6 AU/ml; p = 0.003) and adiponectin levels (9.8 +/- 4.6 vs. 8.4 +/- 4.0 microg/ml; p < 0.001) were significantly higher in the low adiponectin/PAI-1 groups. The difference in PAI-1 remained significant after adjustment for age and BMI (p = 0.001), became borderline significant after adjustment for age and VAT (p = 0.052), and disappeared after adjustment for age and HOMA-IR (p = 0.116) or age and HDL-chol (p = 0.443). The difference in adiponectin levels remained significant after adjustment for age, VAT, HOMA-IR and hs-CRP (p = 0.006), but disappeared after additional adjustment for HDL-chol (p = 0.089). Further analyses suggest a contribution of HOMA-IR and/or HDL-chol in the relationship between PAI-1 and adiponectin. HDL-chol was found to be the only factor independently determining both factors. In conclusion, in overweight and obese women, PAI-1 activity was inversely related to serum adiponectin, independent of visceral adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16411393

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

Review 1.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

2.  Contribution of genetic and metabolic syndrome to omental adipose tissue PAI-1 gene mRNA and plasma levels in obesity.

Authors:  Luigi Bouchard; Marie-Claude Vohl; Stéfane Lebel; Frédéric-Simon Hould; Picard Marceau; Jean Bergeron; Louis Pérusse; Pascale Mauriège
Journal:  Obes Surg       Date:  2010-02-02       Impact factor: 4.129

Review 3.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

4.  Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors.

Authors:  Theodoros Dimitroulas; Karen M J Douglas; Vasileios F Panoulas; Tracey Toms; Jacqueline P Smith; Gareth J Treharne; Peter Nightingale; James Hodson; George D Kitas
Journal:  Clin Rheumatol       Date:  2013-05-15       Impact factor: 2.980

5.  Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator System.

Authors:  Jennifer C Carter; Frank C Church
Journal:  J Oncol       Date:  2011-10-29       Impact factor: 4.375

6.  Aging- and obesity-related peri-muscular adipose tissue accelerates muscle atrophy.

Authors:  Shunshun Zhu; Zhe Tian; Daisuke Torigoe; Jiabin Zhao; Peiyu Xie; Taichi Sugizaki; Michio Sato; Haruki Horiguchi; Kazutoyo Terada; Tsuyoshi Kadomatsu; Keishi Miyata; Yuichi Oike
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

Review 7.  Short-Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy.

Authors:  Maciej Ziętek; Zbigniew Celewicz; Małgorzata Szczuko
Journal:  Nutrients       Date:  2021-04-09       Impact factor: 5.717

8.  Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.

Authors:  Jennifer C Carter; Frank C Church
Journal:  PPAR Res       Date:  2009-08-06       Impact factor: 4.964

Review 9.  Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  Curr Cardiol Rev       Date:  2012-11

10.  Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease.

Authors:  João Tomé-Carneiro; Manuel Gonzálvez; Mar Larrosa; María J Yáñez-Gascón; Francisco J García-Almagro; José A Ruiz-Ros; Francisco A Tomás-Barberán; María T García-Conesa; Juan Carlos Espín
Journal:  Cardiovasc Drugs Ther       Date:  2013-02       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.